KRYS- Krystal Biotech, Inc.
Krystal Biotech, Inc. (KRYS) has 8 insiders with recent SEC Form 4 filings, including 4 buys and 0 sells. KRYS is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.50M | $514.88M | - | |
| Pres | 1.43M | $490.15M | - | |
| Dir | 75.7K | $25.98M | - | |
| Dir | 5.0K | $1.72M | - | |
| Dir | 5.0K | $1.72M | - |
Activity
Buys and sells only
Transactions
4 filings · page 8
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2018 | Krishnan Krish S46 | President And CEO | Buy | 50,000 | $11.00 | $550,000.00 | +2.6% | |
| Sep 22, 2017 | Janney Daniel | Director | Buy | 200,000 | $10.00 | $2,000,000.00 | +153.2% | |
| Sep 22, 2017 | Krishnan Suma46 | Chief Operating Officer | Buy | 100,000 | $10.00 | $1,000,000.00 | +5.4% | |
| Sep 22, 2017 | Krishnan Krish S46 | President And CEO | Buy | 100,000 | $10.00 | $1,000,000.00 | +5.4% |
← PrevPage 8